These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38693561)

  • 1. Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time.
    Shaaban A; Petersen A; Beckwith H; Florea N; Potter DA; Yee D; Vogel RI; Duprez D; Blaes AH
    Cardiooncology; 2024 May; 10(1):27. PubMed ID: 38693561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time.
    Shaaban A; Petersen A; Beckwith H; Florea N; Potter DA; Yee D; Vogel RI; Duprez D; Blaes AH
    Res Sq; 2023 Apr; ():. PubMed ID: 37066265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study.
    Blaes A; Beckwith H; Florea N; Hebbel R; Solovey A; Potter D; Yee D; Vogel R; Luepker R; Duprez D
    Breast Cancer Res Treat; 2017 Nov; 166(2):541-547. PubMed ID: 28801846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of aromatase inhibitors in early breast cancer.
    Chung CT; Carlson RW
    Curr Treat Options Oncol; 2003 Apr; 4(2):133-40. PubMed ID: 12594939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson LJ; Dawson C; Lawrence DH; Bliss JM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated peripheral endothelial function among women treated with aromatase inhibitors for breast cancer.
    Maor R; Sara JDS; Wanous AA; Maor E; Pruthi S; Lerman A; Sandhu NP
    Coron Artery Dis; 2018 Dec; 29(8):687-693. PubMed ID: 30379695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
    Roberts KE; Rickett K; Feng S; Vagenas D; Woodward NE
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012988. PubMed ID: 31994181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putting the cardiovascular safety of aromatase inhibitors in patients with early breast cancer into perspective: a systematic review of the literature.
    Younus M; Kissner M; Reich L; Wallis N
    Drug Saf; 2011 Dec; 34(12):1125-49. PubMed ID: 22077502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study.
    Cao A; Zhang J; Liu X; Wu W; Liu Y; Fan Z; Zhang A; Zhou T; Fu P; Wang S; Ouyang Q; Tang J; Jiang H; Zhang X; Pang D; He J; Shi L; Wang X; Sheng Y; Mao D; Shao Z
    Health Qual Life Outcomes; 2016 Mar; 14():51. PubMed ID: 27009092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Melisko ME; Goldman ME; Hwang J; De Luca A; Fang S; Esserman LJ; Chien AJ; Park JW; Rugo HS
    JAMA Oncol; 2017 Mar; 3(3):313-319. PubMed ID: 27832260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson L; Lawrence D; Dawson C; Bliss J
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD003370. PubMed ID: 19821307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer.
    Henry NL; Conlon A; Kidwell KM; Griffith K; Smerage JB; Schott AF; Hayes DF; Williams DA; Clauw DJ; Harte SE
    J Pain; 2014 May; 15(5):468-75. PubMed ID: 24462504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.
    Hanamura T; Hayashi SI
    Breast Cancer; 2018 Jul; 25(4):379-391. PubMed ID: 28389808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective.
    Conte P; Frassoldati A
    Breast J; 2007; 13(1):28-35. PubMed ID: 17214790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular safety profiles of aromatase inhibitors : a comparative review.
    Nabholtz JM; Gligorov J
    Drug Saf; 2006; 29(9):785-801. PubMed ID: 16944964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
    Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with body composition changes in women on aromatase inhibitors for ER (+) breast cancer.
    Napoli N; Rastelli A; Ma C; Colleluori G; Vattikuti S; Armamento-Villareal R
    Pharmacogenet Genomics; 2015 Aug; 25(8):377-81. PubMed ID: 26049585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors.
    Cepa M; Vaz C
    Acta Reumatol Port; 2015; 40(4):323-30. PubMed ID: 26922195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo - Meta-analyses on efficacy and adverse events based on randomized clinical trials.
    Rydén L; Heibert Arnlind M; Vitols S; Höistad M; Ahlgren J
    Breast; 2016 Apr; 26():106-14. PubMed ID: 27017249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.